American Shared Hospital Services, a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, will hold a conference call on March 31st at 12:00 pm ET to discuss its fourth quarter and full year 2025 financial results. The company, which trades on the NYSE American under the symbol AMS, will issue its financial results press release before the market opens on the same day. This announcement provides stakeholders with an opportunity to assess the company's performance across its equipment leasing and direct patient care services segments.
Domestic callers can participate by dialing 1-844-413-3972, while international callers may use 1-412-317-5776. Participants are advised to dial in at least 10 minutes prior to the start of the call. A simultaneous webcast of the conference call will be accessible through the company's website at https://www.ashs.com or directly via https://event.choruscall.com/mediaframe/webcast.html?webcastid=QqZruHXQ. This allows broader access for investors and analysts who wish to follow the discussion remotely.
A replay of the call will be available through April 7, 2026, by dialing 1-855-669-9658 or 1-412-317-0088 and using access code 6331493. The replay will also be archived on the company's website at https://www.ashs.com. This ensures that those unable to attend the live event can still review the financial details and management commentary at their convenience.
The conference call is significant as it offers transparency into the financial health of a company specializing in critical cancer treatment technologies. American Shared Hospital Services provides turnkey solutions to cancer treatment centers, health systems, and cancer networks in North and South America, focusing on developing and growing cancer service lines to deliver integrated care locally. The discussion may address the company's Gamma Knife, proton therapy, and advanced radiation therapy businesses, which are subject to various risks including economic conditions, variability of quarterly results, and changes to CMS reimbursement rates.
Investors should note that the press release includes a safe harbor statement cautioning that forward-looking statements involve risks and uncertainties. Further details on potential factors affecting the company are included in its filings with the Securities and Exchange Commission, such as Quarterly Reports on Form 10-Q and the Annual Report on Form 10-K. The upcoming conference call serves as a key event for evaluating the company's trajectory in the competitive healthcare technology sector, where financial performance directly impacts its ability to provide essential cancer treatment solutions to medical facilities across the Americas.
